Serina Therapeutics, Inc.
SER·NYSE American·Healthcare
1.6900−0.1400 (−7.65%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.8300
Open1.7000
Day range1.62551.8000
52-week range1.22004.4480
Off day high−6.11%
Off 52-week high−62.01%
Volume39.63K
Avg. volume (3M)70.18K
Market cap42.93M
EPS (TTM)-1.87
Forward P/E-1.61
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.15
Shares outstanding25.40M
Short interest0.20% of float
Earnings dateAug 4, 2025 (est.)
Analyst target9.5000
Profit margin0.00%
Against its peers
Compare in full ›| SER | SVA.TO | PMN | LONA | INO | RANI | |
|---|---|---|---|---|---|---|
| Market cap | 42.93M | 39.65M | 31.57M | 43.01M | 167.50M | 80.49M |
| P/E (TTM) | — | 10.5 | — | — | — | — |
| Forward P/E | -1.6 | -3.5 | -0.8 | — | -3.9 | -3.0 |
| Price/book | 2.3 | -1.7 | 0.6 | 1.3 | 30.6 | 1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −58.98% | −26.67% | −63.90% | +13.84% | −27.51% | −77.76% |
| Today | −7.65% | −8.70% | +3.23% | −4.30% | −2.41% | +3.06% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SER news ›Serina Therapeutics Streamlines Capital Structure After Preferred Elimination
Serina Therapeutics ( (SER) ) has issued an update. The most recent analyst rating on (SER) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Serina Therapeutics stock, see the SER Stock Forecast page.…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Negativesentiment
Mentioned with
People in the coverage
Themes
Most coverage from
- theglobeandmail.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.